ArticleAmerican journal of translational research2020

Metastatic brain tumors respond favorably to pyrotinib in a HER2-positive breast cancer following failure using trastuzumab.

Jing-Hao Yao et al.PubMed ↗Full text ↗

No numbers read from the abstract.